Tasso, M. et al. 2022. Effectiveness and safety profile of tofacitinib and baricitinib in rheumatoid arthritis patients: results from a 24-month real-life prospective study in Southern-Italy. Reumatismo. 74, 3 (Dec. 2022). DOI:https://doi.org/10.4081/reumatismo.2022.1511.